MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2353/ajpath.2009.090332

Медицинская библиотека · The American journal of pathology · 2009

Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice.

Mitchell Claudia, Robin Marie-Anne, Mayeuf Alicia, Mahrouf-Yorgov Meriem, Mansouri Abdellah, Hamard Marie, Couton Dominique, Fromenty Bernard, Gilgenkrantz Hélène

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Accumulating evidence indicates that oxidative stress is involved in the physiopathology of liver fibrogenesis. However, amid the global context of hepatic oxidative stress, the specific role of hepatocyte mitochondrial dysfunction in the fibrogenic process is still unknown. The aim of this study was to determine whether a targeted protection of hepatocytes against mitochondrial dysfunction could modulate fibrosis progression. We induced liver fibrogenesis by chronic carbon tetrachloride treatment (3 or 6 weeks of biweekly injections) in transgenic mice expressing Bcl-2 in their hepatocytes or in normal control mice. Analyses of mitochondrial DNA, respiratory chain complexes, and lipid peroxidation showed that Bcl-2 transgenic animals were protected against mitochondrial dysfunction and oxidative stress resulting from carbon tetrachloride injury. Picrosirius red staining, alpha-smooth muscle actin immunohistochemistry, and real-time PCR for transforming growth factor-beta and collagen alpha-I revealed that Bcl-2 transgenic mice presented reduced fibrosis at early stages of fibrogenesis. However, at later stages increased nonmitochondrial/nonhepatocytic oxidative stress eventually overcame the capacity of Bcl-2 overexpression to prevent the fibrotic process. In conclusion, we demonstrate for the first time that specific protection against hepatocyte mitochondrial dysfunction plays a preventive role in early stages of fibrogenesis, delaying its onset. However, with the persistence of the aggression, this protection is no longer sufficient to impede fibrosis progression.

Для цитирования: Mitchell Claudia, Robin Marie-Anne, Mayeuf Alicia, Mahrouf-Yorgov Meriem, Mansouri Abdellah, Hamard Marie, Couton Dominique, Fromenty Bernard, Gilgenkrantz Hélène. Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice.. The American journal of pathology. 2009. DOI: 10.2353/ajpath.2009.090332.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.